News

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.
The mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key immune ...
IO Biotech said on Monday its experimental cancer vaccine, in combination with Merck's Keytruda, showed improvement in a late ...
New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.
Canceling federal mRNA vaccine projects threatens much more than pandemic response, according to Michigan State University’s ...
The "off-the-shelf" vaccine has also shown promising results for pancreatic cancer. Since the U.S. Preventive Services Task ...
IO Biotech said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's ...
Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine ...